DARGAN CHARLES K 4
4 · BIOLARGO, INC. · Filed Jan 5, 2021
Insider Transaction Report
Form 4
BIOLARGO, INC.BLGO
DARGAN CHARLES K
Chief Financial Officer
Transactions
- Award
Option to purchase common stock
2020-12-31+7,500→ 3,588,286 totalExercise: $0.12From: 2020-12-31Exp: 2030-12-31→ Common stock (7,500 underlying)
Footnotes (2)
- [F1]This Option was granted to Reporting Person to replace options to purchase an aggregate 30,000 shares of Issuer's common stock that had been issued approximately 10 years ago to compensate Reporting Person for services to the Issuer and had recently expired unexercised due to a discrepancy between the original exercise price and the Issuer's current stock price, pursuant to a plan adopted by the Issuer's Compensation Committee.
- [F2]This amount reflects, in addition to the reported option grant, the expiration, during the fourth quarter of 2020, of options to purchase an an aggregate 30,000 shares of common stock.